C4 Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in C4 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including C4 Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in C4 Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $641k | 114k | 5.65 |
| 2023-09-30 | $407k | 219k | 1.86 |
| 2023-06-30 | $634k | 231k | 2.75 |
| 2023-03-31 | $1.1M | 346k | 3.14 |
| 2022-12-31 | $1.7M | 284k | 5.90 |
| 2022-06-30 | $993k | 132k | 7.54 |
| 2022-03-31 | $2.9M | 120k | 24.26 |
| 2021-12-31 | $7.2M | 225k | 32.20 |
| 2021-09-30 | $12M | 264k | 44.68 |
| 2020-12-31 | $418k | 13k | 33.11 |